psychiatry
Lithium Therapy Monitoring
Lithium initiation, therapeutic monitoring, and toxicity management
Source: NICE CG185 / BNF
Step 1 of ~8
info
Lithium Initiation
Indication: bipolar disorder (prevention of mania/depression), recurrent depression, augmentation. Pre-lithium: U&E, TFTs, eGFR, FBC, weight, ECG, pregnancy test.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Hydroxychloroquine (Ophthalmic Toxicity Monitoring) · Antimalarial — Ophthalmic Toxicity Monitoring Drug
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Chloride 3% (Hypertonic Saline) · Hypertonic Electrolyte Solution — ICP/Hyponatraemia Management
- Estradiol (HRT — Hormone Replacement Therapy) · Oestrogen Replacement Therapy
- Allopurinol · Xanthine Oxidase Inhibitor — Urate-lowering Therapy
- Febuxostat · Xanthine Oxidase Inhibitor — Urate-lowering Therapy
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Alcohol Withdrawal Management · NICE CG115 2010 / BNF
Decision support only. Always apply local guidelines and clinical judgement.